PT  - JOURNAL ARTICLE
AU  - Kumar, N P
AU  - Wild, G
AU  - Ramasamy, K A
AU  - Snape, J
TI  - Fatal haemorrhagic pulmonary oedema and associated angioedema after the ingestion of rofecoxib
AID  - 10.1136/pmj.78.921.439
DP  - 2002 Jul 01
TA  - Postgraduate Medical Journal
PG  - 439--440
VI  - 78
IP  - 921
4099  - http://pmj.bmj.com/content/78/921/439.short
4100  - http://pmj.bmj.com/content/78/921/439.full
SO  - Postgrad Med J2002 Jul 01; 78
AB  - Angioedema is a recognised side effect of rofecoxib, a cyclo-oxygenase-2 (COX-2) inhibitor. But death resulting from a haemorrhagic pulmonary oedema after its ingestion has not been recorded. The case of a 60 year old man who died from haemorrhagic pulmonary oedema in the presence of angioedema after the ingestion of two doses of 12.5 mg of rofecoxib is reported.